🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for AML, Adult

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse NCT06928662Phase 1, Phase 21 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Decitabine, Bone Marrow Aspiration, Bone Marrow Biopsy, Chest Radiography, Cytarabine Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome NCT00801489Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Cytarabine, Decitabine, Filgrastim-sndz, Fludarabine Phosphate, Gemtuzumab Ozogamicin Assessment of Geriatric Evaluations Impact on New AML Guidance NCT05909501n/a1 site📍 Philadelphia Abramson Cancer Center at Penn Medicine Cord Blood Transplantation in Children and Young Adults With Blood Cancer NCT07566377Phase 21 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: Cord Blood Units, Total Body Irradiation, Cyclophosphamide, Fludarabine, Clofarabine Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT NCT05917405Phase 223 sites📍 Nantes📍 Amiens📍 Angers Nantes University Hospital · Tests: Fludarabine, Busulfan, ATG, Clofarabine Study of SA+X in the Treatment of Newly Diagnosed AML NCT07548710Phase 21 site📍 Shanghai Ruijin Hospital · Tests: Anthracycline, Ivosidenib, Gilteritinib, Sonrotoclax, Azacitidine (AZA) Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome NCT06128070Phase 21 site📍 Duarte City of Hope Medical Center · Tests: Biospecimen Collection, Chest Computed Tomography, Echocardiography, Hematopoietic Cell Transplantation, Methotrexate Venetoclax Basket Trial for High Risk Hematologic Malignancies NCT05292664Phase 15 sites📍 San Francisco📍 Aurora📍 Atlanta Andrew E. Place, MD · Tests: Venetoclax, Azacitidine, Cytarabine, Methotrexate, Hydrocortisone Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML NCT05305859Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: venetoclax combining chidamide and azacitidine (VCA) PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML NCT05105152Phase 11 site📍 Seattle Seattle Children's Hospital · Tests: SC-DARIC33 Precision Therapy Versus Standard Therapy in AML and MDS in Elderly NCT05025098Phase 21 site📍 Lørenskog University Hospital, Akershus · Tests: Standard therapy, Precision therapy Novel Digital Application for Patients With Acute Leukemia NCT06472128NA3 sites📍 Boston📍 Durham📍 Seattle Massachusetts General Hospital · Tests: DREAMLAND, VITAL WELLNESS MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717Phase 21 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: Fludarabine, Busulfan, Melphalan, Rituximab, Levetiracetam Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis NCT06756152Phase 2, Phase 31 site📍 Moscow Federal Research Institute of Pediatric Hematology, Oncolog… · Tests: Conditioning regimen: Treosulfan 42 g/m2/course or total body irradiation 12 Gray/course, Etoposide 60 mg/kg , Fludarab… DEC3-VEN vs. Venetoclax-Based vs. DA Regimens in Newly Diagnosed AML NCT07712848Phase 31 site📍 Kunming The Second Affiliated Hospital of Kunming Medical University · Tests: Arm A (VEN+"2+6"DA), Arm B (DEC3-VEN), Arm C ("3+7"DA) Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study NCT07108530Phase 21 site📍 Taiyuan Shanxi Bethune Hospital · Tests: Integrated IAV/MA Chemotherapy and Allo-HSCT Protocol for Adult AML, First Induction (IAV or DAV Regimen), Consolidatio… Clonal Hematopoiesis Chemotherapy and Radiation Effects Study NCT07675967n/a1 site📍 Boston Dana-Farber Cancer Institute · Tests: Samples A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) NCT01351545n/a142 sites📍 Birmingham📍 Gilbert📍 Phoenix Center for International Blood and Marrow Transplant Resear… · Tests: A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant NCT03326921Phase 11 site📍 Seattle Fred Hutchinson Cancer Center · Tests: CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR, Bone Marrow Aspiration, Biospecimen Collection Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission NCT06824168Phase 264 sites📍 Birmingham📍 Los Angeles📍 Baltimore Daiichi Sankyo · Tests: Quizartinib High Dose, Quizartinib Low Dose Escalation of Doses of Daratumumab in Combination With Chemotherapy (Idarubicin and Cytarabine or CPX-351) in Patients of 60 Years Old or More With Adverse Risk Acute Myeloblastic Leukemia (AML) (DARALAM) NCT05749276Phase 11 site📍 Nantes Nantes University Hospital · Tests: Darzalex Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML) NCT04777916n/a30 sites📍 Amiens📍 Argenteuil📍 Bobigny Acute Leukemia French Association Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia NCT06613217Phase 11 site📍 Houston Pacylex Pharmaceuticals · Tests: zelenirstat Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS NCT05350748n/a1 site📍 Bethesda National Cancer Institute (NCI) Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders NCT04644016Phase 21 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: Clofarabine, Fludarabine, Busulfan, Cyclosporine-A, Mycophenolate Mofetil Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia NCT07014449Phase 11 site📍 Hangzhou Hangzhou Weben Pharma Co., Ltd · Tests: WBC100 QD A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome NCT06501196Phase 113 sites📍 Duarte📍 Los Angeles📍 Palo Alto BlossomHill Therapeutics · Tests: BH-30236, Venetoclax VA vs DA for Newly Diagnosed Hig-risk AML NCT05939180Phase 2, Phase 32 sites📍 Suzhou📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Venetoclax Oral Tablet, Daunorubicin CD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AML NCT07347418Phase 11 site📍 Aurora University of Colorado, Denver · Tests: CD64 CAR T Cells Relation Between Venetoclax Plasma Concentration and Remission in Adults with Acute Myeloid Leukemia (PREDICLAX) NCT06045819n/a1 site📍 Caen University Hospital, Caen · Tests: Blood sampling for venetoclax drug dosage (venous puncture)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy